Objective: The aim of this study was to investigate whether there are differences in capillary nailfold changes in SSc patients with and without pulmonary arterial hypertension (PAH), and whether these changes are associated with PAH severity and disease specificity.
INTRODUCTION
Systemic sclerosis (SSc) represents the main connective tissue disease (CTD) associated with pulmonary arterial hypertension (PAH). 1 PAH complicates an estimated 12% of SSc patients, and is a leading cause of death in patients with SSc. 2 Microvascular dysfunction is considered to be a key element in the pathogenesis of SSc and its complications. 3--5 The majority of SSc patients display characteristic structural changes of the capillaries in the nailfold, consisting of reduction in the number of capillaries (capillary density), and widening of capillary loops. 6--8 A number of studies suggest an association between systemic microvascular changes and organ involvement in SSc 9--11 ; nevertheless, it is not clear whether systemic microvascular changes in SSc are associated with the presence and severity of PAH.
Better knowledge of the association between nailfold capillary characteristics and PAH in SSc could be useful both for better understanding of the pathophysiology of SSc associated PAH, as well as for stratification of SSc patients in terms of PAH risk. Recent developments, including computer based nailfold video capillaroscopy systems, have improved quantitative assessment of microcirculatory changes such as capillary density and loop dimensions. 6 The aim of this study was to test the hypothesis that there are differences in capillary density and capillary dimensions between SScPAH and SSc--nonPAH patients, and that these changes are quantitatively correlated with pulmonary haemodynamic parameters. To test the hypothesis that these changes are SSc specific, a group of IPAH patients, as well as healthy controls were investigated. Computer based panorama mosaic video capillaroscopy was used to display the nailfold capillaries.
MATERIALS AND METHODS

Subjects
Between class II dyspnoea with normal pressures as determined by right heart catheterisation at rest and during exercise. All SSc patients had to have a total lung capacity (TLC) of >70% of predicted, and a pO 2 of >60 mmHg at rest. Study protocols were approved by the local ethics committee.
Exercise testing and right heart catheterisation
Prior to right heart catheterization, maximal exercise tolerance and peak oxygen uptake (VO 2 max) were assessed by an exercise test on a cycle ergometer. Pulmonary artery pressures (PAP) were taken during right heart catheterisation. Cardiac output (CO) was determined and pulmonary vascular resistance (PVR) was calculated as the ratio of mean PAP to CO. Cardiac index (CI) is defined as the CO divided by the body surface area.
Haemodynamic measurements were obtained at baseline and, if baseline mean PAP was less than 25 mmHg, while cycling (see the appendix for further details).
Capillaroscopy
Capillaroscopy and computerised mosaic of the nailfold was obtained as described previously. 6 For this study, only images from digit 4 of the non--dominant hand were used.
Image quality was scored as 'good' or 'moderate'. Cases in which only 'poor' quality images were available, precluding identification of capillary architecture, were excluded from this study (see the appendix for further details). The investigator was blinded to patient diagnosis and laboratory results; all images were coded. Capillary density (number of loops per mm) was calculated by computer from the manually marked loops in the terminal row.
Mean apex, arterial, venous and total capillary widths of the 3--5 widest capillaries were measured. In the case of irregular dilatated capillaries, maximal width was measured.
Statistical analysis
Capillary density and dimensions showed a normal distribution in all categories and are presented as means and standard deviations (SD). Data on the duration of Raynaud's phenomenon (RP) and the duration of SSc were positively skewed and are presented as geometric means and 95% confidence interval (CI) of the back--transformed data after log transformation was performed. Numerical means of two or more independent categories were analysed using the Student's t--test or one--way ANOVA, respectively. Differences between the groups with respect to capillary density and loop dimensions, were analysed using analysis of variance with and without adjustment for age and multiple comparisons (Bonferroni). Categorical variables were analysed using the Chi--squared or Fisher's Exact Test when appropriate. Correlation between density and pulmonary haemodynamic parameters were described using Pearson's correlation coefficient. Statistical significance was set at p < 0.05. Results were calculated using computer software (SPSS, version 15.0 for Windows; SPSS; Chicago, IL).
RESULTS
Characteristics of subjects
In 21 (100) 19 (86) 18 (95) 13 (100) 7 (88) † RP (%) 0 1 (5) 17 (90) 13 (100) 8 (100) and loop dimensions were not age related (r = 0.097, p = 0.68 for capillary density and age).
Analysis of differences in capillary density and loop dimensions between groups with and without adjustment for age yielded similar results. 39.2 mmHg, p=0.006), but no other differences in haemodynamic parameters were present.
Capillaroscopy was performed after a median of 5.8 months (range --3 to 48 months) after right heart catheterisation. Time separation was shorter than 18 months in 90% of the patients. 
DISCUSSION
Structural changes in the systemic microcirculation, consisting of reduction of capillary density and widening of capillary dimensions, are a hallmark of SSc. 6--8 A novel finding of this study is that capillary density, but not capillary dimensions, differs between SScPAH and SSc--nonPAH, and correlates with pulmonary haemodynamic parameters. Interestingly, when compared to healthy controls, the same is true for patients with IPAH, a condition not known to be characterised by systemic microvascular changes. Our data suggests that widening of capillaries and capillary density reduction represent two different aspects of systemic microvascular involvement, i.e. widening of capillaries is SSc specific, whereas reduction in capillary density is a marker of the presence and severity of PAH.
Few studies have investigated nailfold capillary patterns in patients with SScPAH, with only one study including patients with IPAH. Two studies used echocardiography and/or right heart catheterisation to confirm the diagnosis of PAH. One of these found a significant reduction of capillary density in 8 SSc patients with PAH in comparison with 12 SSc patients without PAH. 14 No pulmonary haemodynamic parameters were reported in this study. The other study, using capillary density and qualitative scoring of nailfold patterns, found no differences in capillary patterns between 8 SSc--nonPAH and 7 SScPAH patients, but capillary density in these groups was not reported. 15 A third study, using only right heart catheterisation to diagnose and exclude the diagnosis of PAH, showed a significant difference in semi--quantitative scoring of nailfold patterns between SSc--nonPAH and SScPAH but, again, capillary density was not assessed in this study. 16 Only one of these studies included IPAH patients and reported no differences in capillary density and capillary patterns between 13 healthy controls and 37 IPAH patients. 15 In the present study, a reduction of capillary density was observed in both SSc--PAH and, albeit to a milder extent, in IPAH. However, the explanation for capillary density reduction may not be the same for both disorders. For SSc, it is generally presumed that structural changes in the systemic (micro--)circulation precede changes in the pulmonary circulation, since systemic microvascular changes may precede SSc development by many years. 15 Hence nailfold capillary density in patients with heart failure. 18 In addition, we found no association between capillary density and CI or systemic vascular resistance in our PAH patients.
A computer based panorama mosaic video capillaroscopy was used in this study to display a detailed image of a large part of the nailfold, that allows precise measurements of capillary density and loop dimensions. Furthermore, a diagnosis of PAH was confirmed by right heart catheterisation. However, although we feel that in SSc patients with NYHA class I, and no signs of PAH at echocardiography and exercise testing, a diagnosis of PAH was reasonably excluded, right heart catheterisation remains the gold standard. Therefore, some subclinically PAH could not be fully excluded in this group. In addition, the group of patients with SScPAH during exercise was quite small.
From a pathophysiological viewpoint, our study sheds more light on the involvement of the microcirculation in SScPAH and IPAH, although subsequent research is needed to delineate whether the disturbances in the microcirculation are causal or consequential to PAH. From a
